Role of Nutraceuticals in Cancer Chemosensitization

Erscheinungsjahr 2017
ISBN: 978-0-12-812373-7
Verlag: ACADEMIC PR INC

Buch, Englisch, Band 2, 398 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 612 g

Reihe: Cancer Sensitizing Agents for

Role of Nutraceuticals in Chemoresistance to Cancer, Volume Two, focuses on nutraceuticals, the compounds derived from natural sources, which are usually multi-targeted as a means to overcome chemoresistance. This book discusses the role of several compounds related to nutraceuticals and chemoresistance, such as curcumin, resveratrol, indole 3-carbinol, tocotrienols, ursolic acid, fisetin, celastrol, gambogic, butein, catechins and silymarin. It is a valuable resource for cancer researchers, oncologists and members of several areas of the biomedical field who are interested in understanding how to use nutraceuticals as a sensitizing agent for chemotherapy.

Zielgruppe

<p>cancer researchers; oncologists; pharmacists; graduate students on cancer studies.</p>

Autoren/Hrsg.

Bonavida, Benjamin

Weitere Mitwirkende

Bonavida, Benjamin

Aggarwal, Bharat Bhushan

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. Pathways linked to Chemoresistance2. Role of curcumin in chemoresistance3. Role of resveratrol in chemoresistance4. Role of indole 3- carbinol in chemoresistance5. Role of tocotrienols in chemoresistance6. Role of ursolic acid in chemoresistance7. Role of fisetin in chemoresistance8. Role of celastrol in chemoresistance9. Role of gambogic acid in chemoresistance10. Role of butein in chemoresistance11. Role of catechins in chemoresistance12. Role of Silymarin in chemoresistance

Über Autor(innen)

Bonavida, Benjamin
Dr Bonavida has vast expertise and various reported publications in the field of tumor cell sensitization to chemotherapy (a total of greater than 500 publications) and in particular the novel role of Nitric Oxide (NO) donors in chemo-sensitization and reversal of drug resistance. In addition, he was the first scientist to co-organize an international meeting on the topic (First International Workshop on NO and Cancer, 2005).

Aggarwal, Bharat Bhushan
Dr. Aggarwal is currently a Founding Director of the Inflammation Research Center in San Diego, California. He is also currently serving on the Advisory Board of several Nutraceutical companies. Until December 31st, 2015, Dr. Aggarwal was a Ransom Horne Distinguished Professor of Experimental Therapeutics, Cancer Research, Cancer Medicine, Biochemistry and Immunology; and Chief of the Cytokine Research Section, in the Department of Experimental Therapeutics at the University of Texas M. D. Anderson Cancer Center, Houston, Texas. He also served as a member of the University of Texas Graduate School of Biomedical Sciences, Houston, and as an Adjunct Professor at Albert B. Alkek Institute of Biosciences and Technology, Texas A&M University, Houston, Texas.